|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 越南西北部大象山超高温变质岩的发现及其区域构造意义显示文摘越南西北部大象山群孔兹岩系中发育一套含刚玉+尖晶石+石榴石+夕线石组合的富铝岩石块体,它们呈透镜状包体形式赋存于孔兹岩系内。岩石中刚玉+尖晶石+石榴石+夕线石组合的发育指示岩石经历了超高温变质作用的改造。其中尖晶石和石英的共生组合表明了变质温度高于900℃,而利用岩石退变质矿物组合中的黑云母-石榴石温度计,黑云母-斜长石-石榴石-石英组合温度-压力计估算的变质温度压力条件分别为879~917℃、0.90~0.94GPa。岩石中的早期刚玉+夕线石的组合的存在说明岩石变质作用已经从高角闪岩相进入到了麻粒岩相;而峰期变质矿物组合尖晶石+石英的出现,指示了变质温度高于900℃的超高温变质作用。另一方面,退变质过程中钛铁矿的发育表明岩石经历了快速抬升降压的过程。变质作用的P-T轨迹分析揭示出岩石经历了早期同步升温增压后的快速增温达到峰期条件,后经历快速等温减压过程。这种温压条件的变化与板块会聚过程中由于俯冲板片的断离而使软流圈上涌造成热异常的温压条件变化基本一致。通过对超高温变质岩石进行锆石SIMSU-Pb测年获得的结果大于58Ma,推测这次超高温变质与喜马拉雅运动中印度与欧亚大陆的初期会聚-碰撞作用相关。 | 吴虎峻 刘俊来 TRAN My Dung NGUYEN Quang Luat PHAM Binh 吴文彬 陈文 张招崇 | 2011 | 岩石学报2011，27，9： | 4 |
| 2 | 越南O Quy Ho钼矿床的成矿时代及成矿物质来源探讨显示文摘越南西北部O Quy Ho钼矿床为范士版成矿带的典型钼矿床之一,矿体以脉状形式就位于中生代花岗岩中,辉钼矿主要赋存于石英脉及长石石英脉中,与黄铁矿、黄铜矿、磁铁矿等共生。8件样品硫同位素分析结果表明,δ34S介于0.14‰~3.34‰之间,平均值为1.53‰,表明成矿物质具有深源特征。黄铁矿的206Pb/204Pb范围为18.583~22.355,207Pb/204Pb变化于15.632~15.812之间,208Pb/204Pb变化于38.989~39.199;辉钼矿的206Pb/204Pb、207Pb/204Pb、208Pb/204Pb分别为18.686~18.737、15.655~15.660和39.081~39.082,与范士版含角闪石花岗斑岩具有成因联系。辉钼矿Re-Os同位素等时线测年获得了(36±1)Ma的年龄,该年龄与金沙江-红河新生代斑岩铜钼矿成矿带岩浆-成矿活动的年龄一致,提出O Quy Ho钼矿床为金沙江-红河新生代斑岩铜钼矿带的一部分。 | TRAN My Dung 刘俊来 NGUYEN Quang Luat 陈越 邹运鑫 | 2010 | 矿床地质2010，29，2： | 2 |
| 3 | Genetic and clinical determinants influencing warfarin dosing in children with heart disease显示文摘 | Nguyen N Anley P Yu MY | 2013 | Pediatr Cardiol2013，34，4： | 1 |
| 4 | Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection 显示文摘 | Nguyen KB Salazar-Mather TP Dalod MY | 2002 | J Immunol2002，169，8： | 1 |
| 5 | Diabetes mellitus accelerates car- tilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice显示文摘 | Nguyen N Naik V Speer MY | 2013 | Cardiovascular pathology2013，22，2： | 1 |
| 6 | Percutaneous nephrolithotomy in the management of complex upper urinary tract caluli:the Singapore General Hospital experience显示文摘 | Nguyen HD Tan YH Wong MY | 2002 | Ann Acad Med Singapore2002，31，4： | 1 |
| 7 | Determination of bisphenol A BPA by gas chromatography mass spectrometry and 1 HNMR spectroscopy during curing of epoxy amine resins 显示文摘 | Perrin F X Nguyen Thi Minh Hanh Tran Thi My Linh | 2006 | Polymer Testing2006，25，7： | 1 |
| 8 | Pereutaneous nephrolithotomy in the management of complex upper urinary tract calculi :the Singapore General Hospital experience 显示文摘 | Nguyen I- Tan YH Wong MY | 2002 | Ann Acad Med Singapore2002，31，4： | 1 |
| 9 | Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase Ⅱ randomised placebo-controlled double-blind multicentre trial显示文摘Rationale Haematoma growth is common early after intracerebral haemorrhage(ICH),and is a key determinant of outcome.Tranexamic acid,a widely available antifibrinolytic agent with an excellent safety profile,may reduce haematoma growth.Methods and design Stopping intracerebral haemorrhage with tranexamic acid for hyperacute onset presentation including mobile stroke units(STOP-MSU)is a phase Ⅱ double-blind,randomised,placebo-controlled,multicentre,international investigator-led clinical trial,conducted within the estimand statistical framework.Hypothesis In patients with spontaneous ICH,treatment with tranexamic acid within 2 hours of onset will reduce haematoma expansion compared with placebo.Sample size estimates A sample size of 180 patients(90 in each arm)would be required to detect an absolute difference in the primary outcome of 20%(placebo 39%vs treatment 19%)under a two-tailed significance level of 0.05.An adaptive sample size re-estimation based on the outcomes of 144 patients will allow a possible increase to a prespecified maximum of 326 patients.Intervention Participants will receive 1 g intravenous tranexamic acid over 10 min,followed by 1 g intravenous tranexamic acid over 8 hours;or matching placebo.Primary efficacy measure The primary efficacy measure is the proportion of patients with haematoma growth by 24±6 hours,defined as either≥33%relative increase or≥6 mL absolute increase in haematoma volume between baseline and follow-up CT scan.Discussion We describe the rationale and protocol of STOP-MSU,a phase Ⅱ trial of tranexamic acid in patients with ICH within 2 hours from onset,based in participating mobile stroke units and emergency departments. | Nawaf Yassi Henry Zhao Leonid Churilov Bruce C V Campbell Teddy Wu Henry Ma Andrew Cheung Timothy Kleinig Helen Brown Philip Choi Jiann-Shing Jeng Annemarei Ranta Hao-Kuang Wang Geoffrey C Cloud Rohan Grimley Darshan Shah Neil Spratt Der-Yang Cho Karim Mahawish Lauren Sanders John Worthington Ben Clissold Atte Meretoja Vignan Yogendrakumar Mai Duy Ton Duc Phuc Dang Nguyen Thai My Phuong Huy-Thang Nguyen Chung Y Hsu Gagan Sharma Peter J Mitchell Bernard Yan Mark W Parsons Christopher Levi Geoffrey A Donnan Stephen M Davis | 2022 | Stroke & Vascular Neurology2022，7，2： | 1 |
| 10 | Percutaneous nephrolithotomy in the management of complex upper urinary tract calculi:the Singapore General Hospital experience显示文摘 | Nguyen HC Tan YH Wong MY | 2002 | Ann Acad Med Singapore2002，31，4： | 1 |
| 11 | Percutaneous nephrolithotomy in the mangagement of complex upper urinary tract calculi: the Singapore General Hospital experience 显示文摘 | Nguyen HC Tan YH Wong MY | 2002 | Ann Acad Med Singapore2002，31，4： | 1 |
| 12 | Percuaneousnephrolihotomy in the manag ement of complex upperurinary tract calculi:the Singapore General Hospitalexperience显示文摘 | Nguyen HC Tan YH Wong MY | 2002 | Ann Acad Med Singapore2002，31，4： | 1 |
| 13 | State of the art in myeloid sarcoma显示文摘 | Klco JM Welch JS Nguyen TT Hurley MY Kreisel FH Hassan A | | 0，，： | 1 |
| 14 | Consider antilaminin gamma-1 pemphigoid when faced with conflicting histopathology and immunofluorescence results显示文摘 | Kingsbery MY Grossman ME Nguyen H | 2013 | J Am Acad Dermatol2013，68，2： | 1 |
| 15 | Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial显示文摘 | Helena von Hertzen Gilda Piaggio Nguyen Thi My Huong Karine Arustamyan Evelio Cabezas Manuel Gomez Archil Khomassuridze Rashmi Shah Suneeta Mittal Rajasekharan Nair Radnaabazar Erdenetungalag To Minh Huong Nguyen Duc Vy Nguyen Thi Ngoc Phuong Hoang Thi Di | 2007 | The Lancet2007，，9577： | 1 |
| 16 | Localization effects in asymmetrically substituted polythiophenes: Controlled generation of polarons, dimerized polarons, and bipolarons 显示文摘 | Faied Karim Leclerc Mario Nguyen My | 1995 | Macromolecules1995，28，1： | 1 |
| 17 | Percutaneous nephro- lithotomy in the management of complex upper urinary tract cal- culi: the Singapore General Hospital experience 显示文摘 | NGUYEN H D TAN YH WONG MY | 2002 | Ann Acad Med Singapore2002，31，4： | 1 |
| 18 | Market Power, Revenue Diversification and Bank Stability:Evidence from Selected South Asian Countries 显示文摘 | My Nguyen Michael Skully Shrimal Perera | 2012 | Journal of International Financial Markets Institutions & Money2012，22，4： | 1 |
| 19 | Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice 显示文摘 | Nguyen N Naik V Speer MY | 2013 | Cardiovasc Pathol2013，22，： | 1 |
| 20 | Development of a Peristaltic Micropump for Bio-Medical Applications Based on Mini LIPCA显示文摘This paper presents the design,fabrication,and experimental characterization of a peristaltic micropump.The micropump is composed of two layers fabricated from Polydimethylsiloxane(PDMS) material.The first layer has a rectangular channel and two valve seals.Three rectangular mini lightweight piezo-composite actuators are integrated in the second layer,and used as actuation parts.Two layers are bonded,and covered by two Polymethyl Methacrylate(PMMA) plates,which help increase the stiffness of the micropump.A maximum flow rate of 900 μL·min-1 and a maximum backpressure of 1.8 kPa are recorded when water is used as pump liquid.We measured the power consumption of the micropump.The micropump is found to be a prom-ising candidate for bio-medical application due to its bio-compatibility,portability,bidirectionality,and simple effective design. | Thanh Tung Nguyen My Pham Nam Seo Goo | 2008 | Journal of Bionic Engineering2008，5，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员